1. Home
  2. UTSI vs RLYB Comparison

UTSI vs RLYB Comparison

Compare UTSI & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTSI
  • RLYB
  • Stock Information
  • Founded
  • UTSI 1991
  • RLYB 2018
  • Country
  • UTSI China
  • RLYB United States
  • Employees
  • UTSI N/A
  • RLYB N/A
  • Industry
  • UTSI Telecommunications Equipment
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTSI Telecommunications
  • RLYB Health Care
  • Exchange
  • UTSI Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • UTSI 24.9M
  • RLYB 22.0M
  • IPO Year
  • UTSI 2000
  • RLYB 2021
  • Fundamental
  • Price
  • UTSI $2.49
  • RLYB $0.53
  • Analyst Decision
  • UTSI
  • RLYB Hold
  • Analyst Count
  • UTSI 0
  • RLYB 3
  • Target Price
  • UTSI N/A
  • RLYB $15.00
  • AVG Volume (30 Days)
  • UTSI 4.8K
  • RLYB 648.6K
  • Earning Date
  • UTSI 09-04-2025
  • RLYB 08-07-2025
  • Dividend Yield
  • UTSI N/A
  • RLYB N/A
  • EPS Growth
  • UTSI N/A
  • RLYB N/A
  • EPS
  • UTSI N/A
  • RLYB N/A
  • Revenue
  • UTSI $10,878,000.00
  • RLYB $761,000.00
  • Revenue This Year
  • UTSI N/A
  • RLYB N/A
  • Revenue Next Year
  • UTSI N/A
  • RLYB N/A
  • P/E Ratio
  • UTSI N/A
  • RLYB N/A
  • Revenue Growth
  • UTSI N/A
  • RLYB 154.51
  • 52 Week Low
  • UTSI $1.84
  • RLYB $0.22
  • 52 Week High
  • UTSI $3.22
  • RLYB $1.25
  • Technical
  • Relative Strength Index (RSI)
  • UTSI 48.18
  • RLYB 59.91
  • Support Level
  • UTSI $2.19
  • RLYB $0.43
  • Resistance Level
  • UTSI $2.50
  • RLYB $0.59
  • Average True Range (ATR)
  • UTSI 0.08
  • RLYB 0.06
  • MACD
  • UTSI -0.01
  • RLYB -0.00
  • Stochastic Oscillator
  • UTSI 68.18
  • RLYB 65.16

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: